Common Contracts
7 similar Executive Employment Agreement contracts by Keros Therapeutics, Inc.
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • October 16th, 2024 • Keros Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), by and between Keros Therapeutics, Inc. (the “Company”), and Yung H. Chyung (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”), is effective as of November 1, 2024 (the “Effective Date”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 31st, 2022 • Keros Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), by and between Keros Therapeutics, Inc. (the “Company”), and Christopher Rovaldi (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”), is effective as of February 1, 2022 (the “Effective Date”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 2nd, 2021 • Keros Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), by and between Keros Therapeutics, Inc. (the “Company”), and Simon Cooper (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”), is effective as of August 2, 2021 (the “Effective Date”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • April 1st, 2020 • Keros Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), by and between Keros Therapeutics, Inc. (the “Company”), and Keith Regnante (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”), is effective as of the date the Company consummates an initial public offering (the “Effective Date”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • April 1st, 2020 • Keros Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), by and between Keros Therapeutics, Inc. (the “Company”), and Jennifer Lachey (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”), is effective as of the date the Company consummates an initial public offering (the “Effective Date”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • April 1st, 2020 • Keros Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), by and between Keros Therapeutics, Inc. (the “Company”), and Claudia Ordonez (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”), is effective as of the date the Company consummates an initial public offering (the “Effective Date”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • April 1st, 2020 • Keros Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), by and between Keros Therapeutics, Inc. (the “Company”), and Jasbir Seehra (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”), is effective as of the date the Company consummates an initial public offering (the “Effective Date”).
